Hirose Y, Shimizu S, Takiguchi T, Sugai S, Tachibana J, Sawada M, Konda S, Haba T, Yamazaki Y
Jpn J Clin Oncol. 1984 Dec;14(4):601-12.
Ten cases of adult T-cell leukemia-lymphoma (ATL/L) in the Hokuriku district were studied. Five patients were born in endemic areas and later moved to Hokuriku. Five patients were from nonendemic areas, and have not lived in endemic areas. All of the five patients from nonendemic areas had antibody to the adult T-cell leukemia cell-associated antigen (anti-ATLA), and they had anti-ATLA-positive members in their families. Four of the six patients examined had ATL virus (ATLV) proviral DNA in their leukemic cells and type C virus particles were found in the cultured cell line from one of them (case S.D.). The incidence of anti-ATLA in the control population was 0.93% in Ishikawa Prefecture, 0.39% in Toyama Prefecture and 0% in Fukui Prefecture. The overall positive rate in the controls in Hokuriku was 0.49%. The rate of positive anti-ATLA among family members of seven ATL patients (patients are excluded) was 43.5% (17/39). The pedigree study of ATL patients very strongly suggested transmission of ATLV between spouses and transmission from mother to children. We also report a case of ATL from an endemic area, who has been in remission without antileukemic therapy for about one year. He is on 5 FC (5-fluorocytosine), Minomycin (minocycline hydrochloride), and Baktar (trimethoprim-sulfamethoxazole). Possibility that the therapeutic effect of 5 FC on ATL or the remission is due to enhanced cellular immunity after cryptococcus infection is discussed.
对北陆地区的10例成人T细胞白血病-淋巴瘤(ATL/L)病例进行了研究。5例患者出生于流行区,后来迁至北陆地区。5例患者来自非流行区,且未曾在流行区居住过。所有来自非流行区的5例患者均有抗成人T细胞白血病细胞相关抗原抗体(抗ATLA),且其家族中有抗ATLA阳性成员。在检查的6例患者中,有4例患者的白血病细胞中存在ATL病毒(ATLV)前病毒DNA,其中1例患者(病例S.D.)的培养细胞系中发现了C型病毒颗粒。在对照人群中,抗ATLA的发生率在石川县为0.93%,在富山县为0.39%,在福井县为0%。北陆地区对照人群的总体阳性率为0.49%。7例ATL患者(排除患者本人)的家庭成员中抗ATLA阳性率为43.5%(17/39)。对ATL患者的系谱研究强烈提示ATLV在配偶之间传播以及从母亲传给子女。我们还报告了1例来自流行区的ATL病例,该患者在未接受抗白血病治疗的情况下已缓解约1年。他正在服用5 -氟胞嘧啶(5 FC)、二甲胺四环素(米诺环素)和复方新诺明。讨论了5 FC对ATL的治疗效果或缓解是否归因于隐球菌感染后细胞免疫增强的可能性。